https://www.selleckchem.com/btk.html
to lifelong anticoagulant therapy in HHT, as in other very high-bleeding risk patients. Our study suggests that the percutaneous LAA closure in HHT patients with AF could be safe and effective in preventing arterial systemic thromboembolism, also in the presence of reduced or absent post-interventional antithrombotic treatment. LAA occluder implantation can represent a valid and potentially life-saving alternative to lifelong anticoagulant therapy in HHT, as in other very high-bleeding risk patients. To determine whether renin-angiotensin system inh
Like
Comment
Share
